spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Vaccine Manufacturing

Vaccine Manufacturing

23-25 April 2018
RAI, Amsterdam

Changing the shape of vaccine development, manufacturing and delivery

Vaccine Manufacturing 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe. With 900+ attendees, 275+ companies and 4 days of in-depth programmes in specific fields, this year is one not to be missed!
Don't miss this opportunity to achieve success in vaccine manufacturing by benchmarking with leading industry personalities.

SIGN UP NOW AND SAVE MORE: https://lifesciences.knect365.com/vaccine-manufacturing/?vip_code=CQ3568EBR

Contact:
T: +44 (0) 20 3377 3279
E: LS.Registrations@Knect365.com 

phone +44 (0) 20 3377 3279
email LS.Registrations@Knect365.com
web bit.ly/2sOjJdI
email RAI, Amsterdam
 
Print this page
Send to a friend
   
spacer
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

White Papers

Crossing the Blood Brain Barrier (BBB): Which Route to Take?

Aptar Pharma

Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >>


News and Press Releases

ROUSSELOT INTRODUCES X-PURE® GelMA FOR TRANSLATIONAL MEDICINE

Irving, United States [03 June 2020] — Rousselot, a Darling Ingredients brand and the global leader of collagen-based solutions, takes on the digital challenge and introduces X-Pure® GelMA at Bio Digital 2020. The first GMP-ready range of gelatin methacryloyl (GelMA) biomaterials suitable for preclinical and clinical applications, X-Pure® GelMA is part of the X-Pure portfolio of ultra-pure gelatins and collagens, suitable for use as biomaterials in 3D bioprinting, tissue engineering, and regenerative medicine.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement